NCT02794376: MIBS

Mindfulness for Irritable Bowel Syndrome

Completed NA Last updated 27 October 2017

What this trial tests

NA trial testing Mindfulness Based Cognitive Therapy (MBCT) in Irritable Bowel Syndrome in 67 participants. Completed in 10 July 2017.

Timeline

14 April 2016

Primary endpoint
10 July 2017

10 July 2017

Quick facts

Lead sponsor	University of Oxford
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	67
Start date	14 April 2016
Primary completion	10 July 2017
Estimated completion	10 July 2017

Drugs / interventions tested

• Mindfulness Based Cognitive Therapy (MBCT)
• Waiting Period

Conditions studied

• Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →

Sponsor

University of Oxford

Who can join

Adults 18 to 65, female only, with Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effectiveness of a 6 week mindfulness intervention in reducing symptoms of Irritable Bowel Syndrome (IBS). All Participants will receive treatment. Participants will be randomly allocated to an immediate treatment group and a waiting list control group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Gut liver brain axis in diseases: the implications for therapeutic interventions.
   Yan M, Man S, Sun B, Ma L, et al · · 2023 · cited 165× · PMID 38057297 · DOI 10.1038/s41392-023-01673-4